Cargando…

Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y(2) Receptor Based on AR-C118925

[Image: see text] The human P2Y(2) receptor (hP2Y(2)R) is a G-protein-coupled receptor that shows promise as a therapeutic target for many important conditions, including for antimetastatic cancer and more recently for idiopathic pulmonary fibrosis. As such, there is a need for new hP2Y(2)R antagoni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conroy, Sean, Kindon, Nicholas D., Glenn, Jacqueline, Stoddart, Leigh A., Lewis, Richard J., Hill, Stephen J., Kellam, Barrie, Stocks, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026847/ https://www.ncbi.nlm.nih.gov/pubmed/29558126 http://dx.doi.org/10.1021/acs.jmedchem.8b00139

Ejemplares similares

Correction to Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y(2) Receptor Based on AR-C118925
por: Conroy, Sean, et al.
Publicado: (2018)

Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
por: Dekkers, Sebastian, et al.
Publicado: (2023)

Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells
por: Stoddart, Leigh A., et al.
Publicado: (2020)

Development of novel fluorescent histamine H(1)-receptor antagonists to study ligand-binding kinetics in living cells
por: Stoddart, Leigh A., et al.
Publicado: (2018)

Fragment Screening at Adenosine-A(3) Receptors in Living Cells Using a Fluorescence-Based Binding Assay
por: Stoddart, Leigh A., et al.
Publicado: (2012)

Effect of a toggle switch mutation in TM6 of the human adenosine A(3) receptor on Gi protein-dependent signalling and Gi-independent receptor internalization
por: Stoddart, Leigh A, et al.
Publicado: (2014)

Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H(1) Receptor
por: Kok, Zhi Yuan, et al.
Publicado: (2022)

A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A(3) Receptor in Living Cells
por: Arruda, Maria Augusta, et al.
Publicado: (2017)

Efficient G protein coupling is not required for agonist‐mediated internalization and membrane reorganization of the adenosine A(3) receptor
por: Stoddart, Leigh A., et al.
Publicado: (2021)

Kinetic analysis of antagonist-occupied adenosine-A(3) receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism
por: Corriden, Ross, et al.
Publicado: (2014)

Alkylation of Staurosporine to Derive a Kinase Probe for Fluorescence Applications
por: Disney, Alexander J. M., et al.
Publicado: (2016)

Combined Therapy of A(1)AR Agonists and A(2A)AR Antagonists in Neuroinflammation
por: Marucci, Gabriella, et al.
Publicado: (2021)

The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist
por: Li, Xaria X., et al.
Publicado: (2021)

β2AR Antagonists and β2AR Gene Deletion Both Promote Skin Wound Repair Processes
por: Pullar, Christine E, et al.
Publicado: (2012)

Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A(1) receptor ligands
por: Baker, Jillian G, et al.
Publicado: (2010)

Synthesis and Characterization of High-Affinity 4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene-Labeled Fluorescent Ligands for Human β-Adrenoceptors
por: Baker, Jillian G., et al.
Publicado: (2011)

Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
por: Goulding, Joëlle, et al.
Publicado: (2021)

Novel selective β(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease
por: Baker, Jillian G., et al.
Publicado: (2017)

POTENT AND SELECTIVE A2AR MONOCLONAL ANTIBODY ANTAGONIST FOR THE TREATMENT OF CANCER
por: Hu, Changyun, et al.
Publicado: (2023)

Fluorescence‐ and bioluminescence‐based approaches to study GPCR ligand binding
por: Stoddart, Leigh A, et al.
Publicado: (2015)

AR mRNA stability is increased with AR-antagonist resistance via 3′UTR variants
por: Dart, D A, et al.
Publicado: (2019)

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy
por: Leone, Robert D., et al.
Publicado: (2015)

Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists
por: Qi, Yueheng, et al.
Publicado: (2022)

Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson’s Disease
por: Wang, Xuebao, et al.
Publicado: (2017)

27th Annual GP2A Medicinal Chemistry Conference
por: Mistry, Shailesh N., et al.
Publicado: (2019)

Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists
por: Qi, Yueheng, et al.
Publicado: (2022)

Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β (1)‐adrenoceptor expressed in HEK‐293 cells
por: Soave, Mark, et al.
Publicado: (2016)

Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding
por: Khan, Abid, et al.
Publicado: (2007)

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
por: Su, Zijian, et al.
Publicado: (2023)

Cheminformatics analysis of the AR agonist and antagonist datasets in PubChem
por: Hao, Ming, et al.
Publicado: (2016)

NanoBiT Complementation to Monitor Agonist-Induced Adenosine A(1) Receptor Internalization
por: Soave, Mark, et al.
Publicado: (2019)

Quantitative Modeling of GRK-Mediated β2AR Regulation
por: Vayttaden, Sharat J., et al.
Publicado: (2010)

Synthesis and in Vitro and in Vivo Characterization of Highly β(1)-Selective β-Adrenoceptor Partial Agonists
por: Mistry, Shailesh N., et al.
Publicado: (2013)

To Be(Ar) Or Not to Be(Ar) – Jones Dilemma?
por: Andrews, Nicholas A., et al.
Publicado: (2022)

$^{43}$Ar and $^{44}$Ar
por: Hudis, J, et al.
Publicado: (1970)

$^{43}Ar$ and $^{44}Ar$
por: Hudis, J, et al.
Publicado: (1970)

Discovery of Pyridone-Substituted Triazolopyrimidine Dual A(2A)/A(1) AR Antagonists for the Treatment of Ischemic Stroke
por: Tang, Mei-Lin, et al.
Publicado: (2022)

A2AR Transmembrane 2 Peptide Administration Disrupts the A2AR-A2AR Homoreceptor but Not the A2AR-D2R Heteroreceptor Complex: Lack of Actions on Rodent Cocaine Self-Administration
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2019)

QuasAr Odyssey: the origin of fluorescence and its voltage sensitivity in microbial rhodopsins
por: Silapetere, Arita, et al.
Publicado: (2022)

Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes
por: Lay, Charles S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t8242at48f8bmhvp4g390v82b4